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Abstract: 
Background: Extended spectrum beta-lactamases are produced by Gram-negative bacteria and most strains 
producing them belong to the family Enterobacteriaceae. The greatest challenge with ESBL-producing 
Enterobacteriaceae is their propensity to acquire multidrug resistance traits. This study aimed at determining the 
prevalence of ESBL-producing Enterobacteriaceae among selected tertiary hospitals in south-eastern Nigeria. 
Methods: A total of 400 Enterobacteriaceae isolates were obtained from patients attending five selected tertiary 
hospitals and were identified to species level by Gram staining and conventional biochemical tests. Screening for 
ESBL production was determined by the Kirby-Bauer disk diffusion method using 30µg disk of ceftriaxone, 
cefuroxime, cefpodoxime, ceftazidime, and aztreonam while confirmatory test was done using combination disk 
test based on the 2016 CLSI guidelines.                              
Results: The prevalence of ESBL production among Enterobacteriaceae isolates from selected hospitals in 
southeast Nigeria is 61.5% (246 of 400). Among the isolates obtained, the highest prevalence was observed in 
Klebsiella oxytoca (100%) while the least prevalence was seen in Morganella morganii (50.0%). Escherichia coli 
and Klebsiella pneumoniae had rates of 61.8% and 62.3% respectively. Among the States of the south-east 
Nigeria, selected hospital in Ebonyi had a prevalence of 83.5%, Abia 63.6%, Anambra 61.5%, Enugu 51.7% and 
Imo 36.5%. The prevalence of ESBL-producing Enterobacteriaceae differ significantly between the States 
(p=0.000).                              
Conclusion: ESBL-producing Enterobacteriaceae strains have been isolated from different participants, from the 
selected tertiary hospitals in south-eastern Nigeria. Therefore, we report a high prevalence of ESBL-producing 
Enterobacteriaceae in south-eastern Nigeria. 
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Abstrait:                          
Contexte: Les bêta-lactamases à spectre étendu sont produites par des bactéries à Gram négatif et la plupart des 
souches qui les produisent appartiennent à la famille des entérobactéries. Le plus grand défi des entérobactéries 




productrices de BLSE est leur propension à acquérir des traits de résistance multidrogue. Cette étude visait à 
déterminer la prévalence des entérobactéries productrices de BLSE parmi certains hôpitaux tertiaires du sud-est du 
Nigéria.                                
Méthodes: Un total de 400 isolats d'Enterobacteriaceae ont été obtenus de patients fréquentant cinq hôpitaux 
tertiaires sélectionnés et ont été identifiés au niveau de l'espèce par coloration de Gram et tests biochimiques 
conventionnels. Le dépistage de la production de BLSE a été déterminé par les méthodes de diffusion sur disque de 
Kirby-Bauer en utilisant un disque de 30 µg de ceftriaxone, cefuroxime, cefpodoxime, ceftazidime et aztreonam 
tandis que le test de confirmation a été effectué en utilisant un test de disque combiné basé sur les lignes 
directrices de 2017 du CLSI.                               
Résultats: la prévalence de la production de BLSE parmi les isolats d'Enterobacteriaceae provenant d'hôpitaux 
sélectionnés dans le sud-est du Nigeria est de 61,5% (246 sur 400). Parmi les isolats obtenus, la prévalence la plus 
élevée a été observée chez Klebsiella oxytoca (100%) tandis que la prévalence la plus faible a été observée chez 
Morganella morganii (50,0%). Escherichia coli et Klebsiella pneumoniae avaient des taux de 61,8% et 62,3% 
respectivement. Parmi les États du sud-est du Nigéria, certains hôpitaux d'Ebonyi avaient une prévalence de 
83,5%, Abia 63,6%, Anambra 61,5%, Enugu 51,7% et Imo 36,5%. La prévalence des entérobactéries productrices 
de BLSE diffère considérablement d'un État à l'autre (p=0,000).                         
Conclusion: des souches d'entérobactéries productrices de BLSE ont été isolées de différents participants, dans les 
hôpitaux tertiaires sélectionnés du sud-est du Nigéria. Par conséquent, nous signalons une prévalence élevée 
d'entérobactéries productrices de BLSE dans le sud-est du Nigéria. 
Mots-clés: BLSE, Enterobacteriaceae, souches résistantes, sud-est du Nigeria 
Introduction: 
 Some bacteria produce beta-lactamase 
enzymes which renders β-lactam antimicrobial 
agents inactive by hydrolyzing the beta-lactam 
rings thereby conferring resistance against β-
lactam antibiotics. However, bacteria which 
produce beta-lactamases usually express 
resistance to other antimicrobial agents and as 
such frustrate therapeutic interventions (1). 
Extended spectrum beta-lactamases (ESBLs) 
are a group of enzymes that possess the ability 
to deactivate the beta-lactam rings of 
penicillins, first, second and third generation 
cephalosporins, and aztreonam, but they are 
inhibited by clavulanic acid (2). There are 
several molecular variants of ESBLs designated 
as TEM-1, TEM-2, SHV, OXA, CTX-M and PER 
amongst others but the most prevalent types 
are TEM and SHV enzymes (3).   
 ESBLs are chromosomally or plasmid-
mediated. When plasmid-mediated, they are 
encoded on large plasmids that also carry 
genes which mediate resistance to other 
antimicrobial agents such as tetracyclines, 
aminoglycosides, chloramphenicol, trimetho- 
prim and sulphonamides. Therefore, organisms 
which produce ESBLs usually manifest 
resistance to multiple antibiotic classes (4), 
thereby posing very serious therapeutic 
challenges from limited treatment options, with 
severe, and in some cases, fatal clinical 
outcomes (2). Being plasmid-encoded, ESBLs 
can easily be transferred from one bacterium 
to another via horizontal gene transfer. 
Although this can occur within the community, 
it is most often observed in healthcare 
facilities, and is a major challenge in 
nosocomial infections. A number of factors 
create suitable conditions for their spread 
within the hospital setting, and these include; 
poor hygienic practices in hospitals especially 
those in developing countries, indiscriminate 
antibiotics use, empirical antibiotic prescription 
and therapy not supported by the laboratory, 
absence of antimicrobial resistance surveillance 
programs and inadequate infection control 
practices (1,5).     
 ESBLs are produced by Gram-negative 
bacteria and most strains producing them 
belong to the family Enterobacteriaceae. The 
most common mechanisms of resistance to 
third generation cephalosporins by Entero- 
bacteriaceae are through the production of 
ESBLs. These organisms are not only present 
within the hospital settings but have become 
prevalent also in the community. Furthermore, 
ESBLs have been isolated from commensals in 
human, animals and sewage. Therefore, 
environment may serve as reservoirs of 
organisms producing ESBLs (6), which have 
been reported to be responsible for the 
worldwide spread of ESBLs (7).   
 The emergence of ESBLs in Entero- 
bacteriaceae compromises the efficacy of 
antibiotics, and infections due to these 
organisms are associated with high morbidity, 
mortality and treatment costs (3,8). By far, the 
greatest challenge associated with ESBL-
producing Enterobacteriaceae is their propen- 
sity to acquire multidrug resistance traits. 
Other challenges are gross limitation of treat- 
ment options, prolonged hospital stay and 
ability to spread from persons both within the 
hospital and the community with epidemic 
potential, and also to become established as 
endemic pathogen within community (9,10). 
 The drugs of choice for treatment of 
infections caused by ESBL-producing Entero- 
bacteriaceae are the carbapenems. However, 




with these strains becoming endemic, there 
have been increasing dependence and 
widespread use of the carbapenems and at 
present, studies have reported the presence of 
resistance to carbapenems (11). Furthermore, 
failure of antibiotic therapy has resulted in high 
mortality rates in patients infected with these 
bacteria (12). Globally, resistance to anti- 
microbial agents has been identified as a 
menace to public health (13), and developing 
countries are major regions for these multidrug 
resistant bacteria (14).    
 There have been studies conducted at 
different times in individual State of the south-
eastern region of Nigeria but none had been 
conducted across all the States at once. 
Therefore, this study aimed to determine the 
prevalence of ESBL-producing Enterobacteria- 
ceae isolates obtained from selected tertiary 
hospitals in each of the five States that make 
up the south-eastern region of Nigeria. 
Materials and methods: 
Study area     
 The southeastern region of Nigeria lies 
within the coordinates 5o25’N and 8o05’E, and 
is made up of five States; Abia, Anambra, 
Ebonyi, Enugu and Imo. It has an area of 
approximately 76,000 square kilometers. 
According to the 2006 census, the population 
of the region was approximately 16,395,555. 
The region has three types of vegetation; 
mangrove swamps and tidal waterways 
dominate the coastal areas; tropical rainforests 
dominate the regions further north of the 
swamps while guinea savannah dominates the 
northernmost parts of the region. 
Study design and sampling technique   
 This was a cross-sectional study 
designed and carried out in five selected 
tertiary hospitals in south-eastern Nigeria. 
Among eleven tertiary hospitals located within 
the region, five were selected by simple 
random sampling technique. 
Study population    
 The participants were patients who 
presented with clinical manifestations that 
suggested the presence of infection(s) caused 
by any member of the Enterobacteriaceae, 
whose appropriate clinical specimens were sent 
to the microbiology laboratory of each hospital 
for microscopy, culture and sensitivity.  
Ethical consideration    
 Ethical approval was obtained from the 
State Ministries of Health of Abia, Ebonyi, 
Enugu and Imo States, with approval numbers; 
AB/MH/AD/904 /T.167, EBSMOH/ERC/061/19, 
MH/MSD/REC18/045, and CON/MH/MD/195/1 
respectively. Informed consent was obtained 
from the participants or from their parents/ 
guardians (for those below 18 years). The 
participants were assured that their identities 
will not be linked to any data. The study was 
conducted following strict adherence to 
international, national and institutional ethical 
guidelines and in accordance with the 1964 
Helsinki declaration and its later amendments 
or comparable ethical standards. 
Sample size     
 The sample size was calculated using 
the formula; N=Z2PQ/d2 where; N=minimum 
sample size, Z=1.96 (Standard deviation of a 
normal distribution taken at 95% confidence 
interval which corresponds to 1.96), d=0.05 
(degree of accuracy set at 0.05 for 95% 
confidence interval, and P=50% (expected 
prevalence from available literature, however, 
no previous epidemiological study of this 
nature has been conducted within the study 
area hence a prevalence of 50% was 
assumed), and Q=1-P. Therefore, N=1.962x 
0.5(1-0.5)/0.052 gives an estimated sample 
size of 384, which was increased to 400 to 
compensate for 10% attrition.    
 To determine the number of samples 
that would be collected from each centre, the 
probability proportion by size was calculated. 
To determine this, the average number of 
patients received in the medical microbiology 
laboratory from each centre per month was 
obtained (Table 1). The formula used to 
calculate the sample size to be collected from 
each centre was given as “a/b x n”, where 
a=average total patients received by each 
centre per month, b=total number of patients, 
and n=sample size. 
Inclusion and exclusion criteria:  
 Patients who gave informed consents 
and in whom Enterobacteriaceae were isolated 
from their specimens were included in the 
study. Patients who gave consent but in whom 
Enterobacteriaceae was not isolated from their 
specimens were excluded from the study. Also, 
based on the prescription on the patients’ case 
folder and on verbal interview, patients on 
combined antibiotic therapy were excluded 
from the study.  
Specimen collection and bacteria identification: 
 Specimens were collected from the 
participants based on the requests on their 
laboratory request forms. Enterobacteriaceae 
were isolated from various specimens such as 
urine, sputum, cerebrospinal fluids, stool, 




blood, semen, wound, high vaginal, ear, 
throat, urethral and eye swabs.  
 The identification of the isolates was 
performed using standard microbiological 
methods described by Cheesbrough (15) and 
Forbes et al., (16), which includes Gram 
reaction and conventional biochemical tests 
such as indole, methyl red, Voges-Proskauer, 
citrate utilization, oxidase, urease, triple sugar 
iron, and sugar fermen- tation reactions.  
Antimicrobial susceptibility testing  
 Antimicrobial susceptibility testing was 
done using Kirby-Bauer disk diffusion test. 
Mueller-Hinton agar plates were prepared 
following the Manufacturer’s instructions. Using 
sterile swab sticks for each isolate, the plates 
were seeded with 0.5 McFarland turbidity equi- 
valent of the bacterial suspension made on 
sterile normal saline, they were then allowed 
to stand for 20 minutes. Thereafter standard 
antimicrobial disks were placed on the surface 
of the media, each disk being well spaced from 
the other. The plates were subsequently 
incubated in ambient air at 370C for 18 hours. 
Results were read and interpreted using 
guidelines of the Clinical and Laboratory 
Standards Institute (17). 
Screening for ESBL-production                           
 All Enterobacteriaceae isolates were 
first screened for ESBL production using Kirby-
Bauer single disk diffusion with ceftriaxone 
(30µg), cefuroxime (30µg), cefpodoxime (30 
µg), ceftazidime (30µg) and aztreonam (30µg) 
(Oxoid, UK). Isolates with inhibition zones ˂ 27 
mm (ceftriaxone), ˂ 25mm (cefuroxime), ˂ 22 
mm (cefpodoxime and ceftazidime) and ˂ 25 
mm (aztreonam) were preliminary identified as 
ESBL producers and subjected to phenotypic 
confirmatory test. 
Confirmatory test for ESBL production   
 Confirmatory test for ESBL production 
was done with combination disk test described 
by CLSI (17) with minor modifications, using 
ceftazidime disk in combination with clavulanic 
acid. 10 µL of a 1000 µg/10ml stock solution of 
clavulanic acid was added to ceftazidime disks 
each day of testing. A ≥5mm increase in zone 
diameter of the combined disk over the zone 
diameter of single ceftazidime disk confirmed 
an isolate as ESBL-producer.  
Data analysis     
 Data were analysed with the Statistical 
Package for the Social Sciences (SPSS) version 
20.0. Bar and pie charts were used for the 
presentation of some variables; descriptive 
analysis, frequency tables and percentages 
were used for univariate analysis while Chi 
square test was used for bivariate analysis.              




Table 1: Sample size calculation from the probability proportion by size 
 
S/N Centre (a) Sample size (n) 

































































 A total of 400 patient participants were 
enrolled in the study, among these, 192 (48%) 
were males while 208 (52%) were females 
(male: female ratio was approximately 1:1). 
The age group of the participants and the total 
number obtained from each of the State is 
presented in Table 2. The specimen types 
collected from the participants are presented in 
Table 3. The most frequently collected speci- 
mens were urine from 137 (34.3%), stool from 
50 (12.5%), and wound swab from 50 (12.5%) 
while eye swab was the least frequently 
collected specimens from 1 (0.3%) participant. 
 The Enterobacteriaceae isolates 
obtained from the specimens and the 
frequency distribution is presented in Table 4. 
Among the isolates, Escherichia coli had the 
highest overall frequency (30.8%), followed by 
Klebsiella pneumoniae (19.3%) while Klebsiella 
oxytoca had the least frequency of 0.3%. 
Other organisms isolated include; Citrobacter 
freundii, Yersinia enterocolitica, Salmonella 
enterica, Enterobacter aerogenes, Providencia 
stuartii, Shigella sonnei, Proteus mirabilis, 
Morganella morganii and Serratia marcescens. 
 The prevalence of confirmed ESBL-
producing Enterobacteriaceae is presented in 
Table 5. Among the 400 isolates, 246 (61.5%) 
were ESBL producers while 154 (38.5%) were 
non-producers. Among the ESBL producers, E. 
coli had a frequency of 61.8% (76/123) while 
K. pneumoniae had a frequency of 62.3% 
(48/77). However, the highest frequency was 
observed among K. oxytoca (100%) followed 
by S.  sonnei (77.8%), E. aerogenes (77.3%) 
and Y. enterocolitica (64.3%) while the least 
frequency was observed in M. morganii 
(50.0%). When subjected to statistical 
analysis, the prevalence of ESBL-producers 
among the isolates tested was non-significant 
(p=0.721).    
 When the prevalence of ESBL-
producing isolates was compared within the 
age group of the participants, there was no 
significant relationship between age group 
distribution and the prevalence of ESBL-
producing Enterobacteriaceae (p=0.834). How- 
ever, the highest ESBL-producing organisms 
were isolated from participants within the age 
group of 70 years and above (70.0%), followed 
by age group 60-69 (63.6%) whereas age 
group 40-49 years had the least rate of ESBL- 
producing Enterobacteriaceae (51.4%). 
 When the prevalence rates of ESBL-
producing Enterobacteriaceae were compared 
among the five States of the southeast region, 
Ebonyi had the highest prevalence rate 
(83.5%) while Imo had the least (36.5%). The 
prevalence rates for other States were 51.7% 
for Enugu, 61.5% for Anambra and 63.6% for 
Abia (Table 6). The prevalence rates of ESBL-
producing Enterobacteriaceae differed signific- 
antly between the States (p=0.000). 
 
 
Table 2: Demographic variables of patients from whom Enterobacteriaceae were isolated 
Demographic variables Frequency Percentage 
State   
 Abia 77 19.3 
 Ebonyi 103 25.8 
 Enugu 116 29.0 
 Imo 52 13.0 
 Anambra 52 13.0 
Age group (year)   
 <20 71 17.8 
 20-29 124 31.0 
 30-39 46 11.5 
 40-49 35 8.8 
 50-59 28 7.0 
 60-69 66 16.5 
 70 & above 30 7.5 
Gender   
 Male 192 48.0 








Table 3: Frequency distribution of the specimen types obtained from selected patients 
Specimen types Frequency Percentage 
Urine 137 34.3 
Stool 50 12.5 
Wound swab 50 12.5 
Blood 34 8.5 
High vaginal swab 32 8.0 
Endocervical swab 29 7.3 
Semen 17 4.3 
Sputum 14 3.5 
Ear swab 11 2.8 
Throat swab 10 2.5 
Urethral swab 8 2.0 
Cerebrospinal fluid 7 1.8 
Eye swab 1 0.3 
 
Table 4: Frequency distribution of the Enterobacteriaceae isolates   
Isolate Frequency Percentage 
Escherichia coli 123 30.8 
Klebsiella pneumoniae 77 19.3 
Citrobacter freundii 41 10.3 
Yersinia enterocolitica 28 7.0 
Salmonella enterica 27 6.8 
Enterobacter aerogenes 22 5.5 
Providencia stuartii 19 4.8 
Shigella sonnei 18 4.5 
Proteus mirabilis 17 4.3 
Morganella morganii 14 3.5 
Serratia marcescens 13 3.3 
Klebsiella oxytoca 1 0.3 
 
Table 5: Distribution of Enterobacteriaceae isolates by ESBL production 
Isolate ESBL production  χ2 p-value 




Total (%)  
E. coli   47 (38.2) 76 (61.8) 123 (30.8) 7.918 0.721 
K. pneumoniae 29 (37.7) 48 (62.3) 77 (19.3) 







S. enterica 12 (44.4) 15 (55.6) 27 (6.8) 
E. aerogenes 5 (22.7) 17(77.3) 22 (5.5) 
P. stuartii 9 (47.4) 10(52.6) 19 (4.8) 
Shigella sonnei 4 (22.2) 14(77.8) 18 (4.5) 
P. mirabilis 8 (47.1) 9 (52.9) 17 (4.3) 
M. morganii 7 (50.0) 7 (50.0) 14 (3.5) 
S. marcescens 5 (38.5) 8 (61.5) 13 (3.3) 
K. oxytoca 0  1 (100) 1 (0.3)   
Total 154 (38.5) 246 (61.5) 400 (100)   
 
Table 6: Distribution of Enterobacteriaceae and ESBL production in relation to the States of southeastern Nigeria  
 
 State 





Total (%)  
Abia 28 (36.4) 49 (63.6) 77 (19.3) 39.560 0.000 
Ebonyi 17 (16.5) 86 (83.5) 103 (25.8)   
Enugu 56 (48.3) 60 (51.7) 116 (29.0)   
Imo 33 (63.5) 19 (36.5) 52 (13.0)   
Anambra 20 (38.5) 32 (61.5) 52 (13.0)   
Total 154 (38.5) 246 (61.5) 400 (100)   





 This study is essential to raise the 
awareness about the magnitude of the problem 
associated with multidrug resistant bacteria 
with the aim of initiating discussions that can 
lead to formulation of policies or changes in 
the existing policies as well as the enforcement 
of infection control and antibiotic resistance 
surveillance programs in the southeast region. 
This is by providing current data on the 
prevalence of ESBL producing Enterobacteria- 
ceae, taking into cognizance the potential for 
these resistant strains to spread within the 
hospital setting and the community, as well as 
to other regions both within and outside 
Nigeria. Our study objective is in line with 
those from other countries (13,14,18,19). 
 The prevalence of ESBLs is known to 
vary widely worldwide, even in regions that are 
closely related. Several studies conducted in 
different regions of Nigeria on Entero- 
bacteriaceae have reported varying prevalence 
rates for ESBL-production. A rate of 9.3% was 
reported for Enterobacteriaceae in Kano (20) 
while 2.5% for E. coli and 5% for K.  pneumo- 
niae were reported in Ogun State (21). Our 
study reported prevalence rate of 61.5% for 
ESBL-production among Enterobacteriaceae 
isolates in selected hospitals in the south-
eastern region of Nigeria. This is higher than 
the prevalence rates reported from other parts 
of Nigeria (20,21) and 36.9% rate reported in 
Central India (22). When compared with 
previously published data in Ebonyi State, 
there appeared to be a sustained surge in the 
prevalence of ESBL-producing Enterobacteria- 
ceae isolates from 16.5% in 2008 (23), 52% 
among E. coli in 2019 (24), to 83.5% in the 
present study.    
 The prevalence rates reported from 
Enugu State have also varied over the years. 
In 2009, a rate of 11.4% was reported among 
Enterobacteriaceae isolates (25), and 56.6% 
for K.  pneumoniae and 59.4% for E. coli in 
2010 (26). In 2017, prevalence rates of 59.7% 
and 40.4% for Klebsiella spp and E. coli 
respectively were reported among isolates 
obtained from orthopaedic wounds (27). 
Among paediatric population in Enugu metro- 
polis, a prevalence rate of 19.8% for confirmed 
ESBL-producing Enterobacteriaceae was repor- 
ted from both healthy and ill participants (28), 
Another study reported 35% rate among E. coli 
isolates and 75.7% from hospital-acquired 
infection (29). The presence of ESBL-producing 
organisms among paediatric population is a 
cause for concern as it portends an 
establishment    of    the    strains    in   Enugu  
 
metropolis. Also, the observed increasing 
prevalence from 2009 to 2019 is an indication 
of either a non-existent measure to curb the 
menace of antibiotic resistance or a dilapi- 
dation of such control measures if they are 
available.     
 In Abia State, a 50.8% prevalence rate 
of ESBL-producers was reported for urinary 
isolates in Aba (30), which is slightly lower 
than the rate obtained from the present study. 
However, there are no prevalence data on 
isolates from Umuahia where this current study 
was conducted. The least prevalence rate 
(36.5%) reported in our study was among 
isolates obtained from Owerri, which is 
comparable to the prevalence of 26.4% for 
ESBL-producing E. coli reported in 2018 (31). 
However, Duru et al., (32) reported a preva- 
lence of 17% of ESBL-producing E. coli and K.  
pneumoniae among asymptomatic persons in 
Owerri, which represents a group of individuals 
who may serve as reservoirs of these resistant 
strains. Worse still, dissemination can continue 
unnoticed within the community resulting in 
the establishment as an endemic strain within 
the locality.    
 Other studies have detected the 
presence of ESBL-producing Enterobacteria- 
ceae from animal samples within the south-
eastern Nigeria (33). They have also been 
detected among consumables both within and 
outside the region. In Abakaliki, a prevalence 
of 8% was reported from anal swabs of 
donkeys (34) while 33.3% rate was reported 
from frozen mackerel fishes sold in the 
markets (35). In Enugu metropolis, a 
prevalence of 24.2% was reported among 
healthy pigs (36), and in Owerri, a prevalence 
of 22.2% was reported among poultry (37). In 
other regions, Abubakar and colleagues repor- 
ted a prevalence of 8.9% and 5.7% for ESBL-
producing E. coli in chickens and retail eggs in 
Sokoto metropolis (38).   
     
Conclusion: 
 To the best of our knowledge, this is 
the first study to analyse specimens for ESBL-
producing Enterobacteriaceae from the entire 
south-eastern States. Because no study of this 
nature has been conducted in Umuahia, the 
results of this present study provide the first 
information on the prevalence of ESBL-
producing Enterobacteriaceae in Umuahia. 
Generally, our study reports a high prevalence 
rate of 61.5% for ESBL-producing Entero- 
bacteriaceae in south-eastern Nigeria. 
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